Various protease-activation bioluminogenic probes have been designed using a similar strategy to image the furin activity in breast tumors (Dragulescu-Andrasi et al., 2009) or to detect caspase 3 activity in gliomas (Shah et al., 2005). The gene discussed is CASP3; the disease is glioma.